Key facts
- This page summarizes D. Keith Grossman's Form 4 filing for Outset Medical, Inc. (OM).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Mar 2025, 16:23.
D. Keith Grossman - 07 Mar 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)
- Reporting relationship
- Director
- Issuer ticker
- OM
- Reported as of
- 07 Mar 2025
- Net transaction value
- +$150,000
- SEC form
- 4
- Accepted by SEC
- 11 Mar 2025, 16:23:58 UTC
- Prior SEC filing
- 04 Mar 2025
- Next SEC filing
- 11 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- By: John L Brottem For: D Keith Grossman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
D. Keith Grossman filed Form 4 for Outset Medical, Inc. (OM) on 11 Mar 2025.
Change
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: +$150,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OM
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +187,500
- Change %
- +3616%
- Price
- Shares after
- 192,686
- Date
- 10 Mar 2025
- Ownership
- Grossman Fam Trust
- Footnotes
- F1
OM
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 74,035
- Date
- 07 Mar 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OM
transaction
Derivative
Series A Non-Voting Convertible Preferred
Award
- Transaction value
- $150,000
- Shares
- +750
- Change %
- Price
- $200.00
- Shares after
- 750
- Date
- 07 Mar 2025
- Ownership
- Grossman Fam Trust
- Underlying class
- Preferred Stock
- Underlying amount
- 750
- Exercise price
- $0.000000
- Footnotes
- F2
OM
transaction
Derivative
Series A Non-Voting Convertible Preferred
Options Exercise
- Transaction value
- $0
- Shares
- -750
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 10 Mar 2025
- Ownership
- Grossman Fam Trust
- Underlying class
- Preferred Stock
- Underlying amount
- 750
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.
Footnote F2
These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.